This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
How can we reduce the burden of cancer?
Implementing the research agenda of the National Cancer Institute’s Cancer Epidemiology and Genetics Program
Challenge
Scientists at the National Cancer Institute’s (NCI’s) Division of Cancer Epidemiology and Genetics (DCEG) work to understand genetic and environmental determinants of cancer. They study many different types of cancer, employ a wide range of study designs, include diverse populations, and collect a broad array of epidemiologic and clinical data, as well as biological and environmental samples.
These complex, multidisciplinary studies need considerable infrastructure and resources for successful conduct, such as clinical staff and experts in the collection and handling of biological and environmental samples. For many of DCEG’s longitudinal cohort studies, expertise is needed in long-term followup methods and linking cohorts to disease and death registries. Most studies require acquiring, editing, merging, and harmonizing data from multiple sources sometimes collected over the course of many years; maintaining the data in secure databases; and preparing analytic datasets.
Solution
For the past 40 years, Westat has provided research support services to DCEG investigators. We currently hold 6 contracts supporting 50 to 70 active studies.
Our large and highly skilled workforce has advanced, specialized capabilities in
- Multimode data collection from individuals and healthcare delivery sources
- Clinical data collection
- Genetic counseling
- Biological and environmental sample collection and management
- Exposure assessment
- Geospatial analysis
- Data linkages
- Management of complex biomedical data from multiple sources
We successfully manage multiple studies conducted concurrently and respond quickly to address newly emerging scientific questions.
Results
Westat is proud to support research that has made major contributions to our understanding of the causes, progression, prevention, and detection of cancer. Examples include studies that have identified genetic mutations associated with cancer in high-risk individuals, studies to understand the associations of infections with cancer and progression from precancerous lesions, and studies to understand the interrelationships between environmental and genetic factors in cancer.
Focus Areas
Clinical Trials Coordinating Centers Multisite Epidemiology Studies Public HealthCapabilities
Data Collection Data Collection Modes Data Harmonization and Data LinkageSenior Expert Contact
Jeanne Rosenthal
Vice President
-
Perspective
APHA 2023 Recap of Westat’s ActivitiesNovember 2023
Westat staff made a strong impact on the 2023 American Public Health Association (APHA) Annual Meeting & Expo, held in Atlanta, Georgia, November 12-15, 2023!…
-
Perspective
Westat @ APHA 2023November 2023
We’re eager to join our public health colleagues at the American Public Health Association (APHA)’s 2023 Annual Meeting & Expo, in Atlanta, Georgia, November 12-15,…
-
Perspective
Playing a New Role, States Set Visions for Summer LearningNovember 2023
To counter pandemic-related learning loss, the U.S. Department of Education (ED) in March 2021 called on state education agencies (SEAs) and school districts to deliver…